Completion Of The First Batch Of Subject Enrollment For The Phase I Clinical Trial Of The Company » Pr Newswire - New Mobile Phones, Laptops, Gadgets Technology News

Completion Of The First Batch Of Subject Enrollment For The Phase I Clinical Trial Of The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610

Completion Of The First Batch Of Subject Enrollment For The Phase I Clinical Trial Of The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610

...